To assess the safety of 2 transdermal formulations of fentanyl (D-TRANS fentanyl with naltrexone transdermal system and Duragesic (fentanyl transdermal system) in patients with chronic pain who were opioid tolerant. [clinicaltrials_resource:5c8b984a8762a8d1de29ed6ee4c3cb03]
Click here to view the journal abstract from the study manuscript.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To assess the safety of 2 transdermal formulations of fentanyl (D-TRANS fentanyl with naltrexone transdermal system and Duragesic (fentanyl transdermal system) in patients with chronic pain who were opioid tolerant. [clinicaltrials_resource:5c8b984a8762a8d1de29ed6ee4c3cb03]
Click here to view the journal abstract from the study manuscript.
Bio2RDF identifier
5c8b984a8762a8d1de29ed6ee4c3cb03
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5c8b984a8762a8d1de29ed6ee4c3cb03
measure [clinicaltrials_vocabulary:measure]
To assess the safety of 2 tran ...... pain who were opioid tolerant.
description
Click here to view the journal abstract from the study manuscript.
identifier
clinicaltrials_resource:5c8b984a8762a8d1de29ed6ee4c3cb03
title
To assess the safety of 2 tran ...... pain who were opioid tolerant.
@en
type
label
To assess the safety of 2 tran ...... b984a8762a8d1de29ed6ee4c3cb03]
@en